Breaking News Instant updates and real-time market news.

PTVE

Pactiv Evergreen

$13.29 /

-1.14 (-7.90%)

13:21
11/04/21
11/04
13:21
11/04/21
13:21

BofA double upgrades Pactiv Evergreen to Buy after earnings

BofA analyst George Staphos upgraded Pactiv Evergreen to Buy from Underperform with a price target of $18, up from $13, after the company's Q3 results, which were "about in-line with or slightly below" his and Street forecasts. While noting that "clearly there are challenges," Staphos said he was encouraged by what he heard on price and cost, the progress the company is making in improving operations in the Beverage Merchandising segment, and the fact that fiber- and plastic-based products are growing.

  • 04

    Nov

OTHER BREAKING NEWS FROM THE FLY

Options
Chewy call volume above normal and directionally bullish » 13:25
05/24/22
05/24
13:25
05/24/22
13:25
CHWY

Chewy

$22.85 /

-2.02 (-8.12%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$22.85 /

-2.02 (-8.12%)

CHWY Chewy
$22.85 /

-2.02 (-8.12%)

07:39 Today Barclays
Chewy price target lowered to $26 from $41 at Barclays
05/20/22 Jefferies
Pet specialty retail selloff overdone, says Jefferies
04/13/22 JPMorgan
Chewy customer growth to reaccelerate in late 2022, says JPMorgan
03/30/22 Evercore ISI
Chewy price target lowered to $57 from $97 at Evercore ISI
CHWY Chewy
$22.85 /

-2.02 (-8.12%)

CHWY Chewy
$22.85 /

-2.02 (-8.12%)

CHWY Chewy
$22.85 /

-2.02 (-8.12%)

CHWY Chewy
$22.85 /

-2.02 (-8.12%)

General news
Treasury's $47 B 2-year auction was solid » 13:25
05/24/22
05/24
13:25
05/24/22
13:25
$ECON

Economic Data

/

+

Treasury's $47 B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Glencore reports coordinated resolutions with U.S., UK and Brazilian authorities » 13:24
05/24/22
05/24
13:24
05/24/22
13:24
GLNCY

Glencore

$12.91 /

+0.49 (+3.95%)

Glencore announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLNCY Glencore
$12.91 /

+0.49 (+3.95%)

GLNCY Glencore
$12.91 /

+0.49 (+3.95%)

05/12/22 Deutsche Bank
Glencore price target lowered to 580 GBp from 590 GBp at Deutsche Bank
05/03/22 Morgan Stanley
Glencore price target lowered to 620 GBp from 623 GBp at Morgan Stanley
04/29/22 JPMorgan
Glencore price target raised to ZAR 13,200 from ZAR 12,400 at JPMorgan
04/05/22 Deutsche Bank
Glencore price target raised to 590 GBp from 580 GBp at Deutsche Bank
GLNCY Glencore
$12.91 /

+0.49 (+3.95%)

GLNCY Glencore
$12.91 /

+0.49 (+3.95%)

Recommendations
1Life Healthcare price target lowered to $15 from $20 at Piper Sandler » 13:23
05/24/22
05/24
13:23
05/24/22
13:23
ONEM

1Life Healthcare

$8.27 /

-0.525 (-5.97%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$8.27 /

-0.525 (-5.97%)

ONEM 1Life Healthcare
$8.27 /

-0.525 (-5.97%)

05/06/22 Deutsche Bank
1Life Healthcare price target lowered to $11 from $16 at Deutsche Bank
05/05/22 Canaccord
1Life Healthcare price target lowered to $14 from $18 at Canaccord
05/05/22 Citi
1Life Healthcare price target lowered to $14 from $17 at Citi
03/31/22 Credit Suisse
1Life Healthcare assumed with an Outperform at Credit Suisse
ONEM 1Life Healthcare
$8.27 /

-0.525 (-5.97%)

ONEM 1Life Healthcare
$8.27 /

-0.525 (-5.97%)

ONEM 1Life Healthcare
$8.27 /

-0.525 (-5.97%)

ONEM 1Life Healthcare
$8.27 /

-0.525 (-5.97%)

Hot Stocks
Stellantis, Samsung SDI to invest over $2.5B in battery JV in U.S. » 13:22
05/24/22
05/24
13:22
05/24/22
13:22
STLA

Stellantis

$14.12 /

-0.385 (-2.65%)

Stellantis and Samsung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLA Stellantis
$14.12 /

-0.385 (-2.65%)

STLA Stellantis
$14.12 /

-0.385 (-2.65%)

05/17/22 Bernstein
Stellantis initiated with a Market Perform at Bernstein
05/10/22 Berenberg
Stellantis initiated with a Buy at Berenberg
05/09/22 Morgan Stanley
Stellantis price target lowered to EUR 18.50 from EUR 20 at Morgan Stanley
05/06/22 DZ Bank
Stellantis upgraded to Buy from Hold at DZ Bank
STLA Stellantis
$14.12 /

-0.385 (-2.65%)

STLA Stellantis
$14.12 /

-0.385 (-2.65%)

STLA Stellantis
$14.12 /

-0.385 (-2.65%)

STLA Stellantis
$14.12 /

-0.385 (-2.65%)

Periodicals
Rackspace working with Evercore on alternatives review, Inframation says » 13:20
05/24/22
05/24
13:20
05/24/22
13:20
RXT

Rackspace Technology

$8.21 /

-0.45 (-5.20%)

Rackspace Technology is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RXT Rackspace Technology
$8.21 /

-0.45 (-5.20%)

RXT Rackspace Technology
$8.21 /

-0.45 (-5.20%)

05/11/22 Raymond James
Rackspace Technology upgraded to Outperform from Market Perform at Raymond James
05/11/22 Citi
Rackspace Technology price target lowered to $13 from $16 at Citi
05/11/22 Raymond James
Rackspace Technology upgraded to Outperform from Market Perform at Raymond James
04/08/22 Oppenheimer
Rackspace Technology downgraded to Perform from Outperform at Oppenheimer
RXT Rackspace Technology
$8.21 /

-0.45 (-5.20%)

RXT Rackspace Technology
$8.21 /

-0.45 (-5.20%)

Options
Intuit options imply 9.1% move in share price post-earnings » 13:19
05/24/22
05/24
13:19
05/24/22
13:19
INTU

Intuit

$361.00 /

-10.205 (-2.75%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$361.00 /

-10.205 (-2.75%)

INTU Intuit
$361.00 /

-10.205 (-2.75%)

05/20/22 Barclays
Intuit price target lowered to $480 from $585 at Barclays
05/02/22 BMO Capital
Intuit price target lowered to $550 from $600 at BMO Capital
04/25/22 Wells Fargo
Intuit price target lowered to $635 from $725 at Wells Fargo
03/21/22 BMO Capital
Indicators suggest 'slow forming tax season' for Intuit, says BMO Capital
INTU Intuit
$361.00 /

-10.205 (-2.75%)

  • 30
    Nov
INTU Intuit
$361.00 /

-10.205 (-2.75%)

INTU Intuit
$361.00 /

-10.205 (-2.75%)

INTU Intuit
$361.00 /

-10.205 (-2.75%)

Technical Analysis
NASDAQ market internals summary » 13:17
05/24/22
05/24
13:17
05/24/22
13:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 13:16
05/24/22
05/24
13:16
05/24/22
13:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
Under Armour Class A put volume heavy and directionally bearish » 13:15
05/24/22
05/24
13:15
05/24/22
13:15
UAA

Under Armour

$9.18 /

-0.505 (-5.21%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UAA Under Armour
$9.18 /

-0.505 (-5.21%)

UAA Under Armour
$9.18 /

-0.505 (-5.21%)

05/23/22 Citi
Under Armour downgraded to Neutral from Buy at Citi
05/19/22 Williams Trading
Under Armour downgraded to Hold from Buy at Williams Trading
05/19/22 Morgan Stanley
Under Armour downgraded to Equal Weight from Overweight at Morgan Stanley
05/11/22 Argus
Under Armour price target lowered to $15 from $19 at Argus
UAA Under Armour
$9.18 /

-0.505 (-5.21%)

UAA Under Armour
$9.18 /

-0.505 (-5.21%)

UAA Under Armour
$9.18 /

-0.505 (-5.21%)

UAA Under Armour
$9.18 /

-0.505 (-5.21%)

General news
2-year note auction » 13:13
05/24/22
05/24
13:13
05/24/22
13:13
$ECON

Economic Data

/

+

Total Amount: $47B, Rate:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
EOG Resources upgraded to Buy from Hold at Johnson Rice » 13:09
05/24/22
05/24
13:09
05/24/22
13:09
EOG

EOG Resources

$127.11 /

-0.99 (-0.77%)

Johnson Rice analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EOG EOG Resources
$127.11 /

-0.99 (-0.77%)

EOG EOG Resources
$127.11 /

-0.99 (-0.77%)

05/10/22 Raymond James
EOG Resources upgraded to Strong Buy from Outperform at Raymond James
05/10/22 Raymond James
EOG Resources upgraded to Strong Buy from Outperform at Raymond James
05/06/22 BMO Capital
EOG Resources' Q1 report, cash return framework 'positive,' says BMO Capital
04/25/22 Raymond James
EOG Resources price target raised to $170 from $150 at Raymond James
EOG EOG Resources
$127.11 /

-0.99 (-0.77%)

EOG EOG Resources
$127.11 /

-0.99 (-0.77%)

EOG EOG Resources
$127.11 /

-0.99 (-0.77%)

Downgrade
Devon Energy downgraded to Accumulate from Buy at Johnson Rice » 13:08
05/24/22
05/24
13:08
05/24/22
13:08
DVN

Devon Energy

$69.75 /

-1.3 (-1.83%)

Johnson Rice analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVN Devon Energy
$69.75 /

-1.3 (-1.83%)

DVN Devon Energy
$69.75 /

-1.3 (-1.83%)

05/09/22 Raymond James
Devon Energy price target raised to $90 from $85 at Raymond James
05/04/22 Truist
Devon Energy price target raised to $100 from $91 at Truist
04/25/22 Susquehanna
Devon Energy price target raised to $73 from $62 at Susquehanna
04/21/22 Truist
Devon Energy price target raised to $91 from $80 at Truist
DVN Devon Energy
$69.75 /

-1.3 (-1.83%)

DVN Devon Energy
$69.75 /

-1.3 (-1.83%)

General news
Fed Chair Powell was mum on policy in his opening remarks » 13:05
05/24/22
05/24
13:05
05/24/22
13:05
$ECON

Economic Data

/

+

Fed Chair Powell was mum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Options
Trip.com options imply 7.8% move in share price post-earnings » 13:04
05/24/22
05/24
13:04
05/24/22
13:04
TCOM

Trip.com Group

$19.20 /

-1.14 (-5.60%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCOM Trip.com Group
$19.20 /

-1.14 (-5.60%)

TCOM Trip.com Group
$19.20 /

-1.14 (-5.60%)

03/25/22 CLSA
Trip.com Group price target lowered to $35 from $39 at CLSA
03/24/22 Mizuho
Trip.com Group price target lowered to $32 from $35 at Mizuho
03/15/22 Macquarie
Trip.com Group upgraded to Outperform from Neutral at Macquarie
03/14/22 JPMorgan
Trip.com Group downgraded to Neutral on low visibility at JPMorgan
TCOM Trip.com Group
$19.20 /

-1.14 (-5.60%)

TCOM Trip.com Group
$19.20 /

-1.14 (-5.60%)

TCOM Trip.com Group
$19.20 /

-1.14 (-5.60%)

Hot Stocks
BML reports stake in Forte Biosciences, asks for liquidation » 12:59
05/24/22
05/24
12:59
05/24/22
12:59
FBRX

Forte Biosciences

$1.13 /

+0.05 (+4.63%)

BML Investment Partners…

BML Investment Partners reported an 8.94% stake in Forte Biosciences, which represents 1.32M shares. The filing with the SEC allows for activism. On May 24, 2022, BML's Braden Leonard sent an email to Forte Biosciences Chairman and CEO Paul Wagner indicating that BML believes that the company should liquidate and return cash to shareholders. The email reads in part, "After spending some time reflecting on the outcome of the strategic review, it has become clear to me that shareholders would be far better off if the Board had decided to liquidate the company and return cash to shareholders rather than pushing forward with its current plan. FB-102 was not even mentioned until the 10-K filed on 3/31/22, giving the strong impression that the company's new "lead drug" was nothing more than an afterthought until recently...It seems to me that the Board didn't seriously consider liquidation and that the company is being run for the benefit of the few remaining employees rather than shareholders. Had the Board taken decisive action to liquidate, the company could have returned $2.50 to $2.60 per share to shareholders, which is approximately 130-140% above the current quote. This is likely a far better outcome for shareholders than what's to come under the current plan...We strongly recommend that the Board take decisive action to immediately liquidate the company and return cash to shareholders before additional shareholder capital is wasted."

ShowHide Related Items >><<
FBRX Forte Biosciences
$1.13 /

+0.05 (+4.63%)

09/20/21 Chardan
Forte Biosciences upgraded to Neutral from Sell at Chardan
09/03/21 Brookline
Forte Biosciences downgraded to Hold from Buy at Brookline
09/03/21 B. Riley
B. Riley downgrades Forte Biosciences, cuts target to $3 from $73
09/03/21 Ladenburg
Forte Biosciences downgraded to Neutral from Buy at Ladenburg
Options
Teva put volume heavy and directionally bearish » 12:55
05/24/22
05/24
12:55
05/24/22
12:55
TEVA

Teva

$8.38 /

-0.095 (-1.12%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$8.38 /

-0.095 (-1.12%)

TEVA Teva
$8.38 /

-0.095 (-1.12%)

05/17/22 BofA
Teva upgraded to Neutral at BofA on potential opioid deal upside
05/17/22 BofA
Teva upgraded to Neutral from Underperform at BofA
05/04/22 Piper Sandler
Teva downgraded to Underweight from Neutral at Piper Sandler
04/05/22 Barclays
Teva upgraded to Overweight from Equal Weight at Barclays
TEVA Teva
$8.38 /

-0.095 (-1.12%)

TEVA Teva
$8.38 /

-0.095 (-1.12%)

TEVA Teva
$8.38 /

-0.095 (-1.12%)

TEVA Teva
$8.38 /

-0.095 (-1.12%)

Conference/Events
C4 Therapeutics participates in a conference call with JPMorgan » 12:55
05/24/22
05/24
12:55
05/24/22
12:55
CCCC

C4 Therapeutics

$6.30 /

-0.29 (-4.40%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCCC C4 Therapeutics
$6.30 /

-0.29 (-4.40%)

CCCC C4 Therapeutics
$6.30 /

-0.29 (-4.40%)

05/09/22 H.C. Wainwright
C4 Therapeutics price target lowered to $35 from $63 at H.C. Wainwright
05/05/22 Stifel
C4 Therapeutics price target lowered to $14 from $15 at Stifel
04/28/22 Credit Suisse
C4 Therapeutics initiated with an Underperform at Credit Suisse
04/18/22 UBS
C4 Therapeutics price target lowered to $26 from $64 at UBS
CCCC C4 Therapeutics
$6.30 /

-0.29 (-4.40%)

  • 17
    Jun
CCCC C4 Therapeutics
$6.30 /

-0.29 (-4.40%)

Periodicals
Oatly Group lining up eventual CEO successor to Toni Petersson, WSJ reports » 12:54
05/24/22
05/24
12:54
05/24/22
12:54
OTLY

Oatly Group

$3.53 /

-0.175 (-4.73%)

Jean-Christophe Flatin,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTLY Oatly Group
$3.53 /

-0.175 (-4.73%)

OTLY Oatly Group
$3.53 /

-0.175 (-4.73%)

05/05/22 Citi
Oatly Group price target lowered to $10 from $11 at Citi
05/05/22 Piper Sandler
Oatly Group valuation 'very compelling,' says Piper Sandler
05/03/22 Mizuho
Oatly Group price target lowered to $4 from $6 at Mizuho
03/22/22 Truist
Oatly Group price target lowered to $10 from $15 at Truist
OTLY Oatly Group
$3.53 /

-0.175 (-4.73%)

OTLY Oatly Group
$3.53 /

-0.175 (-4.73%)

OTLY Oatly Group
$3.53 /

-0.175 (-4.73%)

OTLY Oatly Group
$3.53 /

-0.175 (-4.73%)

Upgrade
Societe Generale upgrades JPMorgan with $150 target after investor day » 12:49
05/24/22
05/24
12:49
05/24/22
12:49
JPM

JPMorgan

$124.77 /

+0.27 (+0.22%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$124.77 /

+0.27 (+0.22%)

JPM JPMorgan
$124.77 /

+0.27 (+0.22%)

12:38 Today Societe Generale
JPMorgan upgraded to Buy from Hold at Societe Generale
09:10 Today BMO Capital
JPMorgan price target raised to $156 from $150 at BMO Capital
07:59 Today Jefferies
JPMorgan price target raised to $137 from $125 at Jefferies
07:04 Today BofA
JPMorgan event highlighted 'scale and top notch execution,' says BofA
JPM JPMorgan
$124.77 /

+0.27 (+0.22%)

JPM JPMorgan
$124.77 /

+0.27 (+0.22%)

JPM JPMorgan
$124.77 /

+0.27 (+0.22%)

JPM JPMorgan
$124.77 /

+0.27 (+0.22%)

Options
Zillow call volume above normal and directionally bullish » 12:45
05/24/22
05/24
12:45
05/24/22
12:45
Z

Zillow

$38.11 /

-3.24 (-7.84%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Z Zillow
$38.11 /

-3.24 (-7.84%)

Z Zillow
$38.11 /

-3.24 (-7.84%)

05/23/22 Bernstein
Zillow Group initiated with an Underperform at Bernstein
05/20/22 Piper Sandler
Slowing housing market a headwind for Redfin, Zillow, says Piper Sandler
05/06/22 Benchmark
Zillow Group price target lowered to $65 from $115 at Benchmark
05/06/22 Piper Sandler
Zillow Group price target lowered to $39 from $57 at Piper Sandler
Z Zillow
$38.11 /

-3.24 (-7.84%)

Z Zillow
$38.11 /

-3.24 (-7.84%)

Z Zillow
$38.11 /

-3.24 (-7.84%)

Z Zillow
$38.11 /

-3.24 (-7.84%)

Conference/Events
Realogy management to meet virtually with BTIG » 12:45
05/24/22
05/24
12:45
05/24/22
12:45
RLGY

Realogy

$11.35 /

-0.465 (-3.94%)

Homebuilding, Real Estate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RLGY Realogy
$11.35 /

-0.465 (-3.94%)

RLGY Realogy
$11.35 /

-0.465 (-3.94%)

02/22/22 Barclays
Realogy price target raised to $19 from $17 at Barclays
12/20/21 JPMorgan
Realogy upgraded ton positive housing backdrop at JPMorgan
12/20/21 JPMorgan
Realogy upgraded to Overweight from Neutral at JPMorgan
08/31/21 Keefe Bruyette
Realogy upgraded to Outperform from Market Perform at Keefe Bruyette
RLGY Realogy
$11.35 /

-0.465 (-3.94%)

RLGY Realogy
$11.35 /

-0.465 (-3.94%)

RLGY Realogy
$11.35 /

-0.465 (-3.94%)

Upgrade
JPMorgan upgraded to Buy from Hold at Societe Generale » 12:38
05/24/22
05/24
12:38
05/24/22
12:38
JPM

JPMorgan

$125.12 /

+0.62 (+0.50%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$125.12 /

+0.62 (+0.50%)

JPM JPMorgan
$125.12 /

+0.62 (+0.50%)

09:10 Today BMO Capital
JPMorgan price target raised to $156 from $150 at BMO Capital
07:59 Today Jefferies
JPMorgan price target raised to $137 from $125 at Jefferies
07:04 Today BofA
JPMorgan event highlighted 'scale and top notch execution,' says BofA
06:44 Today Wells Fargo
JPMorgan price target raised to $150 from $145 at Wells Fargo
JPM JPMorgan
$125.12 /

+0.62 (+0.50%)

JPM JPMorgan
$125.12 /

+0.62 (+0.50%)

JPM JPMorgan
$125.12 /

+0.62 (+0.50%)

JPM JPMorgan
$125.12 /

+0.62 (+0.50%)

Options
Ally Financial put volume heavy and directionally bearish » 12:35
05/24/22
05/24
12:35
05/24/22
12:35
ALLY

Ally Financial

$39.22 /

-1.175 (-2.91%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLY Ally Financial
$39.22 /

-1.175 (-2.91%)

ALLY Ally Financial
$39.22 /

-1.175 (-2.91%)

04/18/22 Wells Fargo
Ally Financial price target lowered to $50 from $57 at Wells Fargo
04/18/22 Raymond James
Ally Financial price target lowered to $50 from $57 at Raymond James
04/18/22 Piper Sandler
Ally Financial price target lowered to $47 from $54 at Piper Sandler
03/28/22 Morgan Stanley
Ally Financial price target lowered to $55 from $73 at Morgan Stanley
ALLY Ally Financial
$39.22 /

-1.175 (-2.91%)

ALLY Ally Financial
$39.22 /

-1.175 (-2.91%)

General news
Treasury Action: yields are off of their richest levels » 12:35
05/24/22
05/24
12:35
05/24/22
12:35
$ECON

Economic Data

/

+

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.